FDA recall, , High risk
KayserBett IDA Pediatric Care Bed
The pediatric care bed can be operated by a child if not locked, leading to serious injury or death.
Summary by Recall Canary from the FDA notice
What happened
KAYSERBETTEN GMBH & CO. KG, of Bad Fallingbostel, Germany, recalled 372 units of its KayserBett IDA pediatric care bed nationwide in the United States and Canada. The recall began May 4, 2026, and was added to the FDA's Enforcement Report on June 4, 2026.
If the bed's hand control adjustment functions are not locked with the provided key when the patient (child) is unattended, there is an increased risk that the patient or third parties (children) will operate the hand control and trap themselves or others under the bed frame or between the bed frame and the floor.
The product is a pediatric care bed with the product designation KayserBett IDA. The FDA classified the recall on June 4, 2026, and it was in the FDA's weekly enforcement report on June 10, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Pediatric care bed; Product Designation: KayserBett IDA;
Recall details
- Company began the recall
- Sold in
Distribution US Nationwide and Canada.
- Company
- KAYSERBETTEN GMBH & CO. KGBad Fallingbostel, Germany
- Hazard
- Device defect
- Risk
High risk
There is a reasonable chance that using it could cause serious health problems or death.
FDA Class I recall · How risk is rated
- Event ID
- 98820
- Recall number
- Z-2212-2026
- Quantity recalled
- 372 units
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
